Rao Rohan N. Dept. of Forensic Medicine, Medical Jurisprudence and Toxicology, B.J Medical College and Sassoon General Hospitals, Pune, Maharashtra, India
Tatiya Harish S. Dept. of Forensic Medicine, Medical Jurisprudence and Toxicology, B.J Medical College and Sassoon General Hospitals, Pune, Maharashtra, India
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Received : June 01, 2017
Accepted : June 16, 2017
Published : June 30, 2017
Abstract
Organ Transplantation is one of our greatest scientific achievements, a miracle we have come to take for granted due to tremendous advances in medicine. However, the act of harvesting the organs of a deceased individual, though scientifically established, also involves a race against time to prevent ischemia and the ever present possibility of malpractice. Thus the social and legal aspects of organ donation seem to be as, if not more, complicated than the surgical and immunological aspects of transplantation itself. Indian law has various provisions to facilitate organ transplantation; however, rate of deceased donor organ transplantation is just 0.5 per million populations (PMP). In contrast, Spain is a leader in Organ Donation, with rate of 34.4 deceased donations PMP. In this article we aim to study the laws in both countries, and the possibility of adopting some of the policies implemented by Spain, so as to increase the number of donations in India.
References
1. Barker C, Markmann F. Historical Overview of Transplantation. Cold Spring Harb Perspect Med 2013;v3(4):a014977 (https://www.ncbi.nlm. nih.gov/pmc/articles/PMC3684003/).
2. National Deceased Donor Transplantation list 2015– The Mohan Foundation http://www.mohan foundation.org/national-deceased-donor-transplantation.asp (accessed May 20, 2017).
3. Rudge C, Matesanz R, Delmonico F L, Chapman J. International Practices of Organ Donation. Br J Anaesth 2012; 108(suppl_1):i48–i55. (https:// academic.oup.com/bja/article/108/suppl_1/i48/ 237865/International-practices-of-organ-donation).
4. Matesanz R, Dominguez-Gil B, Coll E, dela Rosa G, Marazuela R. Spanish experience as a leading country: what kind of measures were taken? Transplant International 2011; 24:333-343. (http:// onlinelibrary.wiley.com/doi/10.1111/j.1432- 2277.2010.01204.x/full).
5. DGHS Directorate General of Health Services– National Organ Transplant Programme. (http:// d g h s . g o v . i n / c o n t e n t / 1 3 5 3 _ 3 _ N a t i o n a l OrganTransplantProgramme.aspx (accessed May 21, 2017).
6. Zonal Transplant Coordination Centre http:// ztccmumbai.org/ (accessed May 21, 2017).
7. MOHAN Foundation http://www.mohanfoundation. org/who.asp (accessed May 21, 2017).
8. Port F, Bragg-Gresham J, Metzger R, Dykstra D, Gillespie B, Young E, Delmonico F, Wynn J, Merion R, Wolfe R. Held P. Donor characteristics associated with reduced graft survival: an approach to expanding the pool of kidney donors. Transplantation 2009; 74:1281-1286. (http:// journals.lww.com/transplantjournal/Abstract/ 2002/11150/Donor_characteristics_associated_ with_reduced.14.aspx).
9. Ojo A, Hanson J, Meier-Kriesche H, Okechukwu C, Wolfe R, Leichtman A, Agodoa L, Kaplan B, Port F. Survival in recipients of marginal cadaveric donor kidneys compared with other recipients and waitlisted transplant candidates – J Am Soc Neprol 2001; 12:589-597. (http://jasn.asnjournals.org/content/ 12/3/589.full).
10. Routh D, Naidu S, Sharma S, Ranjan P, Godara R. Changing pattern of Donor Selection Criteria in Deceased Donor Liver Transplant: A review of literature. J Clin Exp Hepatol 2013; 3(4):337-346 (https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3940395/).
11. Waiser J, Schreiber M, Budde K, Fritsche L, Bohler T, Hauser I, Neumayer H. Age matching in Renal Transplantation. Nephrol Dial Transplant 2000; 15 (5):696-700. (https://academic.oup.com/ndt/ article/15/5/696/1849971/Age-matching-in-renaltransplantation).
12. Manara A, Murphy P, O’Callaghan G. Donation after circulatory death. Br J Anaesth 2012; 108(suppl_1): i108-i121. (https://academic.oup.com /bja/article/108/suppl_1/i108/237453/Donationafter-circulatory-death).
13. Dominguez-Gil B, Haase-Kromwijk B, Van-Leiden H, Neuberger J, Coene L, Morel P, Corinne A, Muehlbacher F, Brezovsky P, Costa A, Rozental R, Matesanz R. Current situation of donation after circulatory death in European countries. Transplant International 2011; 24:676-686 (http://onlinelibrary. wiley.com/doi/10.1111/j.1432-2277.2011.01257.x/ full).
14. Dominguez-Gil B, Delmonico F, Shaheen F, Matesanz R, O’Connor K, Minina M, Muller E, Young K, Manyalich M, Chapman J, Kiste G, AlMousawi M, Coene L, Garcia V, Gautier S, Hasegawa T, Jha V, Kwek T, Chen Z, Loty B, Costa A, Nathan H, Ploeg R, Reznik O, Rosendale J, Tibell A, Tsoulfas G, Vathsala A, Noel L. The critical pathway for deceased donation: reportable uniformity in the approach to deceased donation. Transplant International 2011; 24:373-378 (http://onlinelibrary. wiley.com/doi/10.1111/j.1432-2277.2011.01243.x/ full).
15. Bramhall S. Presumed consent for organ donation : a case against. Ann R Coll Surg Engl 2011; 93(4): 270-272 (https://www.ncbi.nlm.nih.gov/pmc/ articles/PMC3363073/
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.